Type II

Testosterone Treatment May Help Dieting Men Lose Fat, Fight Diabetes

According to the Department of Medicine at the University of Melbourne in Victoria, Australia, 40 percent of men struggling with obesity have low testosterone. Researchers now believe that adding testosterone treatments to a dieting plan could increase fat reduction.

4 Tips for Diabetic Foot Management

Podiatrists and vascular experts recently developed new diabetic foot management guidelines, according to a Medscape report. Recommendations focus on preventing and relieving major foot issues that can come with diabetes. Here are some highlights of what they recommended.

Electrical Current May Ease Neuropathy Pain

One of the first devices to hit the market is Sensus, by NeuroMetrix. Available by prescription, it relies on external electrical stimulation of nerves and nerve pathways to lessen and control DPN pain in the feet and legs. The device is designed to wrap around the calf under your clothes, and is secured by a […]

New Lifestyle Recommendations for Type 2 Diabetes Released to Endocrinologists

Who tells doctors what to do? Lots of important organizations that help them organize their work. For example, endocrinologist organizations AACE/ACE recently published an updated version of their strategy recommendations (what they call their “algorithm”) for treating type 2 diabetes.

WebMD – Catch-Up Sleep May Reverse Type 2 Diabetes Risk

Though prior research warns that sleep deprivation may increase the risk of type 2 diabetes, a new study suggests that “catch-up” sleep might reverse that risk — at least in the short-term.

FDA approves Basaglar, the first “follow-on” insulin glargine product for TI & TII

The U.S. Food and Drug Administration today approved Basaglar (insulin glargine injection), a long-acting human insulin analog to improve glycemic control in adult and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.

People with Type 2 Diabetes May Be Overtested

Many Americans with type 2 diabetes may be getting unnecessary blood sugar tests — and, in some cases, needless changes in medication, a new study suggests. Researchers found that in a large group of U.S. adults with well-controlled type 2 diabetes, 60 percent were undergoing too many hemoglobin A1C tests.

NPR – Fewer People Are Getting Diabetes, But The Epidemic Isn’t Over

The number of people newly diagnosed with diabetes continues to decline after decades of increases that transformed what was once a disease of the old into a public health crisis that affects even children.

Diabetic Peripheral Neuropathy Can Trip You Up

A new study has shown that adults with diabetic peripheral neuropathy (DPN) are at greater risk of falling during day-to-day activities; this is because they are more likely to have impaired balance.

Red Wine Boosts Heart Health in Type 2 Diabetes

Researchers were precise when they designed the study, including only men and women between the ages of 40 and 75 with stable, type 2 diabetes — they couldn’t need more than two insulin injections a day or be on an insulin pump. People were also excluded if they smoked or had a history of heart […]

TII Diabetes Remission Depends on Type of Weight Loss Surgery

The best type of weight-loss surgery for diabetes control is gastric bypass, according to new research published in JAMA Surgery.

NYT – Ask Well: Reversing TII Diabetes

Studies have shown that both bariatric surgery and extreme low-calorie diets can reverse more established Type 2 diabetes, but “we still need more information on how long the remission is going to last,” Dr. Fradkin said.

The Guardian – Study gives strongest link yet between blood pressure and TII diabetes

The Oxford University study provides the strongest evidence yet of a link between the two conditions. Experts behind the study said more research was needed to see whether using drugs to lower blood pressure would help prevent people developing type 2 diabetes.

The Relationship of Onglyza (Saxagliptin) and Fracture Risk in Type 2 Diabetes

Authors conclude that treatment with Onglyza for type 2 diabetes in older patients was not related with an increased risk of fractures as this was shown by a study encompassing a large population sample. However, an interesting finding between the duration of diabetes and increased risk of bone fracture was discovered, which requires further studies […]

BattleDiabetes – High Intensity Exercise Can Help Type 2 Diabetes

HIIT training – which involves alternating intense bursts of physical activity with periods of rest – was found to improve heart structure and help with diabetes control in a 23-person study funded by the National Institute for Health Research.

New delayed-release metformin may help more patients with type 2 diabetes

The revelation, published in the journal Diabetes Care, means that a delayed-release form of metformin that the researchers tested could suit the 40% of type 2 diabetes patients who cannot use the current formulation.

BBC – Weight loss surgery ‘cures half of type-2 diabetes cases’

The trial, on 60 people, published in the Lancet, found none of those with type 2 had been cured by medication and diet alone. The surgery improves symptoms both through weight loss and by changing the way the gut functions. Experts said the results were “remarkable” and that too few people were getting access to […]

WebMD – Antibiotics Linked to Type 2 Diabetes Risk

Taking antibiotics might increase the risk of developing type 2 diabetes, new research suggests. Danish researchers found that people with type 2 diabetes tended to take more antibiotics in the years leading up to their diagnosis than Danes without the condition.

Ask D’Mine: Insulin Alternatives for Type 2 Diabetes

There are tons of pills for type 2 diabetes. There are pills that coax the pancreas to produce more insulin. There are pills that keep the liver from releasing too much of its stored sugar. There are pills that fight the insulin resistance that is the foundation of type 2 diabetes.

Lilly’s Humalog 200 units/mL KwikPen Now Available in U.S. Pharmacies

Humalog® 200 units/mL KwikPen® (insulin lispro 200 units/mL; U-200), the first and only concentrated mealtime insulin analog in the U.S., is now available in pharmacies. Humalog U-200 KwikPen is a prefilled pen containing a concentrated formulation of Lilly’s rapid-acting insulin Humalog®